• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

男性法布里病患儿的早期肾衰竭。

Early renal failure in childhood in a male with Fabry disease.

机构信息

University College London Medical School, University College London, London, UK.

Lysomal Disorders Unit, Royal Free London NHS Foundation Trust, London, UK.

出版信息

BMJ Case Rep. 2022 May 10;15(5):e246682. doi: 10.1136/bcr-2021-246682.

DOI:10.1136/bcr-2021-246682
PMID:35537774
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9092140/
Abstract

Fabry disease is an X-linked lysosomal storage disorder caused by reduced activity or absence of the alpha-galactosidase A enzyme resulting in systemic accumulation of glycosphingolipids. End-stage renal disease (ESRD) is a late-stage manifestation of Fabry disease, typically presenting in the fifth decade of life, but is very rare in childhood. Here we present a case of an 11-year-old boy with classical Fabry disease presenting with ESRD requiring haemodialysis and transplant. Diagnosis was confirmed by renal biopsy, mutation and low alpha-galactosidase A levels. He has an unusual genotype, hemizygous for the c.1000-11T>A intronic variant and positive for the pseudodeficiency allele D313Y. Due to the possibility of very early and accelerated disease progression, Fabry disease should be considered as a possible diagnosis in unexplained renal failure in males from a younger age.

摘要

法布瑞氏病是一种 X 连锁溶酶体贮积症,由α-半乳糖苷酶 A 活性降低或缺失引起,导致糖鞘脂在全身积累。终末期肾病(ESRD)是法布瑞氏病的晚期表现,通常在生命的第五个十年出现,但在儿童中非常罕见。本文报道了一例 11 岁男孩,患有典型的法布瑞氏病,表现为需要血液透析和移植的 ESRD。诊断通过肾活检、基因突变和α-半乳糖苷酶 A 水平降低得到确认。他的基因型异常,为 c.1000-11T>A 内含子变异的半合子,且存在 D313Y 假缺陷等位基因。由于疾病进展可能非常早且加速,对于年轻男性不明原因的肾衰竭,应考虑法布瑞氏病作为可能的诊断。

相似文献

1
Early renal failure in childhood in a male with Fabry disease.男性法布里病患儿的早期肾衰竭。
BMJ Case Rep. 2022 May 10;15(5):e246682. doi: 10.1136/bcr-2021-246682.
2
High-throughput screening identified disease-causing mutants and functional variants of α-galactosidase A gene in Japanese male hemodialysis patients.高通量筛选鉴定了日本男性血液透析患者α-半乳糖苷酶 A 基因突变体和功能性变异体。
J Hum Genet. 2012 Sep;57(9):575-9. doi: 10.1038/jhg.2012.68. Epub 2012 Jun 14.
3
Systematic DNA Study for Fabry Disease in the End Stage Renal Disease Patients from a Southern Italy Area.意大利南部地区终末期肾病患者法布里病的系统性DNA研究
Kidney Blood Press Res. 2018;43(4):1344-1351. doi: 10.1159/000492593. Epub 2018 Aug 10.
4
Fabry disease with cardiovascular manifestation in a patient with end-stage renal disease.一名终末期肾病患者出现心血管表现的法布里病。
Cesk Patol. 2021 Spring;57(1):49-52.
5
Identification of a novel GLA mutation (Y88C) in a Korean family with Fabry nephropathy: a case report.在一个患有法布里肾病的韩裔家族中鉴定出一种新型GLA突变(Y88C):病例报告。
BMC Med Genet. 2016 Oct 24;17(1):76. doi: 10.1186/s12881-016-0338-7.
6
Novel frameshift mutation in a heterozygous woman with Fabry disease and end-stage renal failure.患有法布里病和终末期肾衰竭的杂合子女性中的新型移码突变。
Am J Nephrol. 1996;16(4):352-7. doi: 10.1159/000169023.
7
Novel α-Galactosidase A Mutation (K391E) in a Young Woman With Severe Cardiac and Renal Manifestations of Fabry Disease.一名患有法布里病严重心脏和肾脏表现的年轻女性中的新型α-半乳糖苷酶A突变(K391E)
Int Heart J. 2016 Sep 28;57(5):637-9. doi: 10.1536/ihj.15-475. Epub 2016 Sep 5.
8
Frequency of Fabry disease in male and female haemodialysis patients in Spain.西班牙血液透析男性和女性患者中 Fabry 病的频率。
BMC Med Genet. 2010 Feb 1;11:19. doi: 10.1186/1471-2350-11-19.
9
Fabry disease: detection of undiagnosed hemodialysis patients and identification of a "renal variant" phenotype.法布里病:未确诊血液透析患者的检测及“肾变异型”表型的鉴定
Kidney Int. 2003 Sep;64(3):801-7. doi: 10.1046/j.1523-1755.2003.00160.x.
10
De novo mutation in a male patient with Fabry disease: a case report.一名法布里病男性患者的新发突变:病例报告
BMC Res Notes. 2014 Jan 7;7:11. doi: 10.1186/1756-0500-7-11.

本文引用的文献

1
Gastrointestinal Involvement in Anderson-Fabry Disease: A Narrative Review.安德森-法布里病的胃肠道受累:一篇叙述性综述。
Int J Environ Res Public Health. 2021 Mar 23;18(6):3320. doi: 10.3390/ijerph18063320.
2
Fabry disease screening in high-risk populations in Japan: a nationwide study.日本高危人群中的法布瑞病筛查:一项全国性研究。
Orphanet J Rare Dis. 2020 Aug 26;15(1):220. doi: 10.1186/s13023-020-01494-6.
3
Newborn screening for Fabry disease in the western region of Japan.日本西部地区法布里病的新生儿筛查。
Mol Genet Metab Rep. 2020 Jan 11;22:100562. doi: 10.1016/j.ymgmr.2019.100562. eCollection 2020 Mar.
4
Mutations in the GLA Gene and LysoGb3: Is It Really Anderson-Fabry Disease?GLA 基因突变与溶酶体β-半乳糖苷酶:真的是安德森-法布里病吗?
Int J Mol Sci. 2018 Nov 23;19(12):3726. doi: 10.3390/ijms19123726.
5
Genetics and Gene Therapy of Anderson-Fabry Disease.安德森-法布里病的遗传学和基因治疗。
Curr Gene Ther. 2018;18(2):96-106. doi: 10.2174/1566523218666180404161315.
6
Early Renal Involvement in a Girl with Classic Fabry Disease.经典型法布里病女童的早期肾脏受累情况
Case Rep Nephrol. 2017;2017:9543079. doi: 10.1155/2017/9543079. Epub 2017 Oct 1.
7
Fabry disease due to D313Y and novel GLA mutations.由D313Y和新的GLA突变导致的法布里病。
BMJ Open. 2017 Oct 6;7(10):e017098. doi: 10.1136/bmjopen-2017-017098.
8
Pathomechanisms of renal Fabry disease.肾型法布里病的发病机制。
Cell Tissue Res. 2017 Jul;369(1):53-62. doi: 10.1007/s00441-017-2609-9. Epub 2017 Apr 12.
9
Screening, diagnosis, and management of patients with Fabry disease: conclusions from a "Kidney Disease: Improving Global Outcomes" (KDIGO) Controversies Conference.法布瑞病患者的筛查、诊断和管理:“肾脏病:改善全球预后”(KDIGO)争议会议的结论。
Kidney Int. 2017 Feb;91(2):284-293. doi: 10.1016/j.kint.2016.10.004. Epub 2016 Dec 18.
10
The coincidence of IgA nephropathy and Fabry disease.IgA 肾病与 Fabry 病的偶合。
BMC Nephrol. 2013 Jan 11;14:6. doi: 10.1186/1471-2369-14-6.